TP53 and adenoma: Next Generation Sequencing has allowed researchers to identify other loss-of-function TP53 mutations (i.e., frameshift/nonsense inactivating mutations or missense copy number loss mutations) in approximately 12.5% of cases of ACTH-secreting adenomas [9,38,42].